What percentage of patients using opioid painkillers experience constipation according to the nurse at Tri-Service General Hospital?

Hung Yu-chun, a nurse at Tri-Service General Hospital's Hospice Ward, stated that about 50% of patients using opioid painkillers experience opioid-induced constipation due to slowed gastrointestinal motility.

What condition did the 50-year-old male patient with stage 4 anal cancer suffer from due to opioid use?

The 50-year-old male patient with stage 4 anal cancer suffered from severe opioid-induced constipation, experiencing no bowel movement for up to two weeks and severe abdominal pain affecting his eating.

Why was the male patient with anal cancer unable to manually defecate despite severe constipation?

The male patient could not manually defecate due to excruciating pain from severe fungating wounds in the perineum and anus, which prevented physical intervention for bowel relief.

What treatment was introduced to improve the patient's bowel function without affecting pain relief?

The patient was switched to peripherally acting μ-opioid receptor antagonists (PAMORAs), which improved bowel function without compromising the pain-relieving effects of his opioid therapy.

What improvement did the patient experience the day after starting PAMORA treatment at Tri-Service General Hospital?

The day after starting PAMORA treatment, the patient successfully passed soft stools, with significant relief from abdominal distension and discomfort, leading to improved quality of life.

AI News NQ Analysis

Opioid Painkiller Users Experience 2 Weeks of Constipation; Doctors Urge Early Discussion of Alternative Therapies

NQ Score 70/100

AI Summary (NQ-processed)

Half of patients taking opioid painkillers experience constipation, with some cases involving two weeks of inability to defecate and severe abdominal pain. A nurse from Tri-Service General Hospital reported a case where an anal cancer patient's quality of life significantly deteriorated due to opioid-induced constipation (OIC), which improved after switching to peripherally acting μ-opioid receptor antagonists (PAMORAs). The president of the Taiwan Academy of Hospice and Palliative Medicine pointed out that OIC can lead to increased depression and low self-esteem, recommending early use of PAMORAs. It was also revealed that patients often find it difficult to discuss this issue with their doctors.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What percentage of patients using opioid painkillers experience constipation according to the nurse at Tri-Service General Hospital?: A: Hung Yu-chun, a nurse at Tri-Service General Hospital's Hospice Ward, stated that about 50% of patients using opioid painkillers experience opioid-induced constipation due to slowed gastrointestinal motility.
Q: What condition did the 50-year-old male patient with stage 4 anal cancer suffer from due to opioid use?: A: The 50-year-old male patient with stage 4 anal cancer suffered from severe opioid-induced constipation, experiencing no bowel movement for up to two weeks and severe abdominal pain affecting his eating.
Q: Why was the male patient with anal cancer unable to manually defecate despite severe constipation?: A: The male patient could not manually defecate due to excruciating pain from severe fungating wounds in the perineum and anus, which prevented physical intervention for bowel relief.
Q: What treatment was introduced to improve the patient's bowel function without affecting pain relief?: A: The patient was switched to peripherally acting μ-opioid receptor antagonists (PAMORAs), which improved bowel function without compromising the pain-relieving effects of his opioid therapy.
Q: What improvement did the patient experience the day after starting PAMORA treatment at Tri-Service General Hospital?: A: The day after starting PAMORA treatment, the patient successfully passed soft stools, with significant relief from abdominal distension and discomfort, leading to improved quality of life.